These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12957437)

  • 1. Clinical course of hypertrophic cardiomyopathy with survival to advanced age.
    Maron BJ; Casey SA; Hauser RG; Aeppli DM
    J Am Coll Cardiol; 2003 Sep; 42(5):882-8. PubMed ID: 12957437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
    Maron BJ; Casey SA; Poliac LC; Gohman TE; Almquist AK; Aeppli DM
    JAMA; 1999 Feb; 281(7):650-5. PubMed ID: 10029128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities.
    Maron BJ; Mathenge R; Casey SA; Poliac LC; Longe TF
    J Am Coll Cardiol; 1999 May; 33(6):1590-5. PubMed ID: 10334429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy with longevity to 90 years or older.
    Maron BJ; Casey SA; Haas TS; Kitner CL; Garberich RF; Lesser JR
    Am J Cardiol; 2012 May; 109(9):1341-7. PubMed ID: 22381158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
    Ommen SR; Maron BJ; Olivotto I; Maron MS; Cecchi F; Betocchi S; Gersh BJ; Ackerman MJ; McCully RB; Dearani JA; Schaff HV; Danielson GK; Tajik AJ; Nishimura RA
    J Am Coll Cardiol; 2005 Aug; 46(3):470-6. PubMed ID: 16053960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
    Olivotto I; Maron MS; Adabag AS; Casey SA; Vargiu D; Link MS; Udelson JE; Cecchi F; Maron BJ
    J Am Coll Cardiol; 2005 Aug; 46(3):480-7. PubMed ID: 16053962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden cardiac death: investigation of the classical risk factors in a community-based hypertrophic cardiomyopathy cohort.
    Anastasakis A; Theopistou A; Rigopoulos A; Kotsiopoulou C; Georgopoulos S; Fragakis K; Sevdalis E; Stefanadis C
    Hellenic J Cardiol; 2013; 54(4):281-8. PubMed ID: 23912920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.
    Maron BJ; Olivotto I; Spirito P; Casey SA; Bellone P; Gohman TE; Graham KJ; Burton DA; Cecchi F
    Circulation; 2000 Aug; 102(8):858-64. PubMed ID: 10952953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
    Maron BJ; Rowin EJ; Casey SA; Haas TS; Chan RH; Udelson JE; Garberich RF; Lesser JR; Appelbaum E; Manning WJ; Maron MS
    Circulation; 2013 Feb; 127(5):585-93. PubMed ID: 23275385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
    Maron MS; Olivotto I; Betocchi S; Casey SA; Lesser JR; Losi MA; Cecchi F; Maron BJ
    N Engl J Med; 2003 Jan; 348(4):295-303. PubMed ID: 12540642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
    J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
    Maeda R; Minami Y; Haruki S; Kanbayashi K; Itani R; Suzuki A; Ejima K; Shiga T; Shoda M; Hagiwara N
    Int J Cardiol; 2016 Jul; 214():419-22. PubMed ID: 27088403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy.
    Thaman R; Gimeno JR; Reith S; Esteban MT; Limongelli G; Murphy RT; Mist B; McKenna WJ; Elliott PM
    J Am Coll Cardiol; 2004 Jul; 44(2):398-405. PubMed ID: 15261938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial bridging in adult patients with hypertrophic cardiomyopathy.
    Sorajja P; Ommen SR; Nishimura RA; Gersh BJ; Tajik AJ; Holmes DR
    J Am Coll Cardiol; 2003 Sep; 42(5):889-94. PubMed ID: 12957438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
    Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival after cardiac arrest in hypertrophic cardiomyopathy.
    Maron BJ; Haas TS; Shannon KM; Almquist AK; Hodges JS
    Heart Rhythm; 2009 Jul; 6(7):993-7. PubMed ID: 19497790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices.
    Shirani J; Aurshiya R; Elshaikh A; Olenchock SA; Rowin EJ; Maron MS; Maron BJ
    Am J Cardiol; 2021 Mar; 142():130-135. PubMed ID: 33279482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.
    Schaff HV; Dearani JA; Ommen SR; Sorajja P; Nishimura RA
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):303-9. PubMed ID: 22154797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.